Finance

Lists
CELC:NASDAQ
Celcuity Inc
$85.21
-5.41%
(-4.87) 1D
Sep 10, 2:20:41 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CELC...
Open
$88.37
High
$89.48
Low
$85.13
Mkt. cap
4.17B
Avg. vol.
799.74K
Volume
447.34K
52-wk high
$151.02
52-wk low
$44.42
EPS
-$4.30
Beta
0.19
Shares outstanding
48.93M
No. of employees
155
Open
$88.37
High
$89.48
Low
$85.13
Mkt. cap
4.17B
Avg. vol.
799.74K
Volume
447.34K
52-wk high
$151.02
52-wk low
$44.42
EPS
-$4.30
Beta
0.19
Shares outstanding
48.93M
No. of employees
155
News stories
From web sources and news partners
About Celcuity Inc
CEO-
Employees155
Founded2011
HeadquartersMinneapolis, Minnesota, United States
SectorBiotechnology
Websitecelcuity.com
Analyst ratings
Based on 10 analysts giving stock ratings to CELC in the past 3 months
Strong buy
Buy
10
Hold
0
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for CELC in the last 3 months.
Highest
Current $85.21
$177.00 (+107.72%)
Average
$160.89 (+88.82%)
Lowest
$140.00 (+64.30%)
Analyst
Recommendation
Action
Price target
Projected
Date
Chase Knickerbocker
Craig-Hallum
Buy
Reiterated
$173.00
+103%
08/18/2026
Bradley Canino
Guggenheim
Buy
Reiterated
$175.00
+105.4%
08/16/2026
Oliver McCammon
LifeSci Capital
Buy
Maintained
$165.00
+93.6%
08/14/2026
Swayampakula Ramakanth
H.C. Wainwright
Buy
Reiterated
$155.00
+81.9%
08/13/2026
Stephen Willey
Stifel Nicolaus
Buy
Maintained
$150.00
+76%
08/14/2026
Eva Fortea Verdejo
Wells Fargo
Buy
Maintained
$166.00
+94.8%
08/14/2026
Gil Blum
Needham
Buy
Reiterated
$140.00
+64.3%
08/14/2026
Tara Bancroft
TD Cowen
Buy
Maintained
-
-
08/13/2026
Unknown Analyst
Leerink Partners
Buy
Maintained
$147.00
+72.5%
07/17/2026
Silvan Turkcan
Citizens JMP
Buy
Maintained
$177.00
+107.7%
07/15/2026
Unknown Analyst
Citizens JMP
Buy
Initiated
$150.00
+76%
04/27/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
34.92M
37.31M
33.06M
31.08M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.93M
11.89M
17.44M
35.04M
Operating expense
42.85M
49.20M
50.51M
66.12M
Total operating expenses
42.85M
49.20M
50.51M
66.12M
Operating income
-42.85M
-49.20M
-50.51M
-66.12M
Other non operating income
-
-
-
-
EBT including unusual items
-43.80M
-50.97M
-52.84M
-78.86M
EBT excluding unusual items
-43.80M
-50.97M
-52.84M
-67.39M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-43.80M
-50.97M
-52.84M
-78.86M
Net profit margin
-
-
-
-
Earnings per share
-0.78
-0.73
-0.86
-1.07
Interest and investment income
3.64M
4.39M
3.75M
4.15M
Interest expense
-4.60M
-6.17M
-6.08M
-5.42M
Net interest expenses
-955.00K
-1.77M
-2.33M
-1.27M
Depreciation and amortization charges
-
-
-
-
EBITDA
-42.81M
-49.15M
-50.46M
-66.06M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps